HomeXTLB • NASDAQ
add
X T L Biopharmaceuticals Ltd
Previous close
$0.84
Day range
$0.82 - $0.91
Year range
$0.77 - $2.57
Market cap
8.46M USD
Avg Volume
69.03K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 405.00K | — |
Operating expense | 769.00K | 284.50% |
Net income | -255.00K | 10.21% |
Net profit margin | -62.96 | — |
Earnings per share | — | — |
EBITDA | -762.25K | -281.60% |
Effective tax rate | 33.77% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.14M | -43.02% |
Total assets | 8.55M | 252.43% |
Total liabilities | 3.12M | 1,412.14% |
Total equity | 5.44M | — |
Shares outstanding | 881.39M | — |
Price to book | 84.00 | — |
Return on assets | -22.77% | — |
Return on capital | -35.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -255.00K | 10.21% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1993
Headquarters
Website
Employees
10
